EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Intercellular adhesion molecule-1 suppresses TMZ chemosensitivity in acquired TMZ-resistant gliomas by increasing assembly of ABCB1 on the membrane

Xin Zhang, Yingying Tan, Tao Li, Dashan Tan, Bin Fu, Mengdi Yang, Yaxin Chen, Mengran Cao, Chenyuan Xuan, Qianming Du, Rong Hu, Qing Wang

Drug Resistance Updates · 2024-09 · 76 · 101112

DOI: 10.1016/j.drup.2024.101112 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Resistance Updates, 2024-09. Verfasst von Xin Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Anhui Medical University, Hefei, Anhui, PR China; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Hefei, …. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Glioma, Intercellular Adhesion Molecule-1, ATP Binding Cassette Transporter, Subfamily B. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIMS: Despite aggressive treatment, the recurrence of glioma is an inevitable occurrence, leading to unsatisfactory clinical outcomes. A plausible explanation for this phenomenon is the phenotypic alterations that glioma cells undergo aggressive therapies, such as TMZ-therapy. However, the underlying mechanisms behind these changes are not well understood. METHODS: The TMZ chemotherapy resistance model was employed to assess the expression of intercellular adhesion molecule-1 (ICAM1) in both in vitro and in vivo settings. The potential role of ICAM1 in regulating TMZ chemotherapy resistance was investigated through knockout and overexpression techniques. Furthermore, the mechanism underlying ICAM1-mediated TMZ chemotherapy resistance was examined using diverse molecular biological methods, and the lipid raft protein was subsequently isolated to investigate the cellular subcomponents where ICAM1 operates. RESULTS: Acquired TMZ resistant (TMZ-R) glioma models heightened production of intercellular adhesion molecule-1 (ICAM1) in TMZ-R glioma cells. Additionally, we observed a significant suppression of TMZ-R glioma proliferation upon inhibition of ICAM1, which was attributed to the enhanced intracellular accumulation of TMZ. Our findings provide evidence supporting the role of ICAM1, a proinflammatory marker, in promoting the expression of ABCB1 on the cell membrane of TMZ-resistant cells. We have elucidated the mechanistic pathway by which ICAM1 modulates phosphorylated moesin, leading to an increase in ABCB1 expression on the membrane. Furthermore, our research has revealed that the regulation of moesin by ICAM1 was instrumental in facilitating the assembly of ABCB1 exclusively on the lipid raft of the membrane. CONCLUSIONS: Our findings suggest that ICAM1 is an important mediator in TMZ-resistant gliomas and targeting ICAM1 may provide a new strategy for enhancing the efficacy of TMZ therapy against glioma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, NeoplasmGliomaIntercellular Adhesion Molecule-1ATP Binding Cassette Transporter, Subfamily BTemozolomideBrain NeoplasmsHumansCell Line, TumorAnimalsAntineoplastic Agents, AlkylatingCell ProliferationMiceMembrane Microdomains

Stichwörter der Autor:innen

ABCB1GliomaICAM1MoesinTMZ-resistance

Substanzen

Intercellular Adhesion Molecule-1ATP Binding Cassette Transporter, Subfamily BTemozolomideABCB1 protein, humanICAM1 protein, humanAntineoplastic Agents, Alkylating

Autor:innen und Institutionen

  • School of Pharmacy, Anhui Medical University, Hefei, Anhui, PR China; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Hefei, Anhui, PR China; State Key Laboratory of Natural Medicines, School of…
  • State Key Laboratory of Natural Medicines, School of Basic Medical and Clinical Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, PR China.
  • State Key Laboratory of Natural Medicines, School of Basic Medical and Clinical Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, PR China; General Clinical Research Center, Nanjing First Hospital, China Phar…
  • General Clinical Research Center, Nanjing First Hospital, China Pharmaceutical University, Nanjing, Jiangsu, PR China.
  • State Key Laboratory of Natural Medicines, School of Basic Medical and Clinical Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, PR China. Electronic address: ronghu@cpu.edu.cn.
  • Department of Neurosurgery, Jiangnan University Medical Center, Wuxi, Jiangsu, PR China. Electronic address: wxwqnj@hotmail.com.

Zitieren

APA

Zhang, X., Tan, Y., Li, T., Tan, D., Fu, B., Yang, M., Chen, Y., Cao, M., Xuan, C., Du, Q., Hu, R., & Wang, Q. (2024). Intercellular adhesion molecule-1 suppresses TMZ chemosensitivity in acquired TMZ-resistant gliomas by increasing assembly of ABCB1 on the membrane. Drug Resistance Updates, 76, 101112. https://doi.org/10.1016/j.drup.2024.101112

Vancouver

Zhang X, Tan Y, Li T, Tan D, Fu B, Yang M, et al. Intercellular adhesion molecule-1 suppresses TMZ chemosensitivity in acquired TMZ-resistant gliomas by increasing assembly of ABCB1 on the membrane. Drug Resistance Updates. 2024;76:101112. doi:10.1016/j.drup.2024.101112

BibTeX
@article{Zhang2024,
  author = {Zhang, Xin and Tan, Yingying and Li, Tao and Tan, Dashan and Fu, Bin and Yang, Mengdi and Chen, Yaxin and Cao, Mengran and Xuan, Chenyuan and Du, Qianming and Hu, Rong and Wang, Qing},
  title = {Intercellular adhesion molecule-1 suppresses TMZ chemosensitivity in acquired TMZ-resistant gliomas by increasing assembly of ABCB1 on the membrane},
  journal = {Drug Resistance Updates},
  year = {2024},
  volume = {76},
  pages = {101112},
  doi = {10.1016/j.drup.2024.101112}
}
Kostenlos starten →